V. Fogal

发表

Regulation of p53 activity in nuclear bodies by a specific PML isoform

P. Pandolfi, P. Sandy, C. Schneider, 2000, The EMBO journal.

Novel Function of the Cyclin A Binding Site of E2F in Regulating p53-Induced Apoptosis in Response to DNA Damage

D. Yap, J. Hsieh, S. Zhong, 2002, Molecular and Cellular Biology.

Cell cycle‐dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315

Xin Lu, J. Hsieh, S. Zhong, 2005, The EMBO journal.

Cell cycle-dependent nuclear retention of p 53 by E 2 F 1 requires phosphorylation of p 53 at Ser 315

Xin Lu, J. Hsieh, S. Zhong, 2013 .

High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile

S. Pastorino, S. Kesari, R. Mukthavaram, 2013, International journal of nanomedicine.

Cooperative nanomaterial system to sensitize, target, and treat tumors

Ji-Ho Park, Erkki Ruoslahti, Michael J. Sailor, 2009, Proceedings of the National Academy of Sciences.

Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma.

Erkki Ruoslahti, E. Ruoslahti, S. Krajewski, 2008, Cancer research.

Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice

E. Ruoslahti, V. Fogal, V. R. Kotamraju, 2011, Proceedings of the National Academy of Sciences.

Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4

Jill P. Mesirov, Justin H Lo, Erkki Ruoslahti, 2012, Science Translational Medicine.

Correction: novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

S. Pastorino, S. Kesari, R. Mukthavaram, 2014, Journal of Translational Medicine.

ASPP1 and ASPP2 are new transcriptional targets of E2F

D. Yap, X. Lu, V. Fogal, 2005, Cell Death and Differentiation.

Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation

Jeffrey W. Smith, E. Ruoslahti, A. Richardson, 2010, Molecular and Cellular Biology.

In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

S. Pastorino, S. Kesari, S. Chien, 2014, British Journal of Cancer.

The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies*

E. Ruoslahti, L. Álvarez-Vallina, V. Fogal, 2010, The Journal of Biological Chemistry.

p53 is involved in the p120E4F-mediated growth arrest

P. Sandy, C. Schneider, V. Fogal, 2000, Oncogene.

Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction

S. Pastorino, Yoon-Jae Cho, S. Kesari, 2014, Oncotarget.

A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma

I. Tsigelny, S. Kesari, V. Kouznetsova, 2017, Journal of Translational Medicine.

Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

Taher Abbasi, Shireen Vali, Milan Makale, 2014, Journal of Translational Medicine.

Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1

A. Hengstermann, M. Scheffner, P. Sandy, 1999, The EMBO journal.

Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4

J. Mesirov, P. Tamayo, W. Hahn, 2012 .

Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature

Sven Christian, E. Ruoslahti, V. Fogal, 2009, Angiogenesis.

Ovarian Cancer Oncogene Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the

J. Mesirov, P. Tamayo, W. Hahn, 2012 .

In vivo tumor cell targeting with "click" nanoparticles.

Yin Ren, S. Bhatia, E. Ruoslahti, 2008, Bioconjugate chemistry.

Tumor Cell Targeting with “ Click ” Nanoparticles

Yin Ren, S. Bhatia, E. Ruoslahti, 2008 .

Correction for Fogal et al., “Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation”

Jeffrey W. Smith, E. Ruoslahti, A. Richardson, 2017, Molecular and Cellular Biology.

In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

S. Pastorino, S. Kesari, Ying S. Chao, 2014, British Journal of Cancer.

A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma

I. Tsigelny, S. Kesari, V. Kouznetsova, 2017, Journal of Translational Medicine.

The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies.

E. Ruoslahti, L. Álvarez-Vallina, V. Fogal, 2011, The Journal of Biological Chemistry.